Reprogramming urokinase into an antibody-recruiting anticancer agent
US-12312621-B2 · May 27, 2025 · US
This page is not indexed by search engines while we improve data quality.
Spiegel David A patents
Spiegel David A is listed as an inventor on 23 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Spiegel David A |
| Total patents | 23 |
| First publication | Mar 24, 2016 |
| Latest publication | May 27, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Therapeutic DNP derivatives and methods using same
US-12168639-B2 · Dec 17, 2024 · US
Synthetic antibody mimetic compounds (SYAMS) targeting cancer, especially prostate cancer
US-12042542-B2 · Jul 23, 2024 · US
Reprogramming urokinase into an antibody-recruiting anticancer agent
US-11920172-B2 · Mar 5, 2024 · US
Reprogramming urokinase into an antibody-recruiting anticancer agent
US-2024067952-A1 · Feb 29, 2024 · US
Therapeutic dnp derivatives and methods using same
US-2024018089-A1 · Jan 18, 2024 · US
Therapeutic DNP derivatives and methods using same
US-11597697-B2 · Mar 7, 2023 · US
Therapeutic DNP derivatives and methods using same
US-11472764-B2 · Oct 18, 2022 · US
Therapeutic dnp derivatives and methods using same
US-2022234989-A1 · Jul 28, 2022 · US
Synthetic antibody mimetic compounds (syams) targeting cancer, especially prostate cancer
US-2022111060-A1 · Apr 14, 2022 · US
Recent patents
Latest publications not already listed above.
Reprogramming urokinase into an antibody-recruiting anticancer agent
US-2021284988-A1 · Sep 16, 2021 · US
Reprogramming urokinase into an antibody-recruiting anticancer agent
US-10961527-B2 · Mar 30, 2021 · US
Synthetic antibody mimetic compounds (SyAMs) targeting cancer, especially prostate cancer
US-10912836-B2 · Feb 9, 2021 · US
Therapeutic dnp derivatives and methods using same
US-2020354306-A1 · Nov 12, 2020 · US
Therapeutic DNP derivatives and methods using same
US-10781161-B2 · Sep 22, 2020 · US
Therapeutic dnp derivatives and methods using same
US-2020087242-A1 · Mar 19, 2020 · US
Reprogramming urokinase into an antibody-recruiting anticancer agent
US-2019359966-A1 · Nov 28, 2019 · US
Therapeutic DNP derivatives and methods using same
US-10457629-B2 · Oct 29, 2019 · US
Synthetic antibody mimetic compounds (syams) targeting cancer, especially prostate cancer
US-2019209696-A1 · Jul 11, 2019 · US
Bifunctional antifungal agents and methods of treating fungal infection
US-2019209572-A1 · Jul 11, 2019 · US
Synthetic antibody mimetic compounds (SYAMS) targeting cancer, especially prostate cancer
US-10117943-B2 · Nov 6, 2018 · US
Therapeutic dnp derivatives and methods using same
US-2016207873-A1 · Jul 21, 2016 · US
Synthetic antibody mimetic compounds (syams) targeting cancer, especially prostate cancer
US-2016082112-A1 · Mar 24, 2016 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ Yale | 23 |
| Merck Sharp & Dohme | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K47/54 | 12 |
| A61K45/06 | 12 |
| C07J41/0055 | 10 |
| A61K31/085 | 10 |
| C07C205/37 | 10 |